Expert Ratings for ShockWave Medical
Portfolio Pulse from Benzinga Insights
ShockWave Medical (NASDAQ:SWAV) has received various analyst ratings over the last quarter, with 2 bullish, 3 somewhat bullish, and 1 indifferent rating. The average 12-month price target among 6 analysts is $252.17, with a high of $284.00 and a low of $218.00. This target is a 15.38% decrease from the previous target of $298.00. Analysts rate stocks based on research and provide guidance on performance metrics.
December 04, 2023 | 5:00 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
ShockWave Medical has a mix of bullish and somewhat bullish ratings, with an average price target of $252.17, reflecting a decrease from the previous target.
The mixed analyst ratings with a majority leaning towards bullish and somewhat bullish suggest a cautiously optimistic outlook for SWAV. The decrease in the average price target may indicate a tempered expectation for the stock's performance, but the absence of bearish ratings could mitigate negative sentiment. The score is neutral due to these counterbalancing factors.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100